Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
odanacatib
.
Show all posts
Showing posts with label
odanacatib
.
Show all posts
Tuesday, September 18, 2012
Merck's Phase III trial assessing fracture risk reduction with odanacatib..
›
Merck announced an update on the Phase III trial assessing fracture risk reduction with odanacatib, (a cathepsin K/cat-K inhibitor see s...
›
Home
View web version
